IRCT201202117373N2已完成1 期
Efficacy of Omega-3 in the treatment of Schizophrenia
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 55 years（—）
- 性别
- All
入选标准
- •age range 15-55years ,diagnosis of schizophrenia according to DSM4-TR criteria and clinical interview by psychiatrist ,informed written consent letter ,a score of at least 60 in PANSS( Positive and Negative Syndrome Scale).
- •Exclusion criteria :Pregnancy ,lactation, substance abuse ,sever physical disease,contraindication of Omega-3
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Effects of Omega-3 fatty acids for psychotic disordersSchizophrenia, at-risk mental state (ARMS)schizophreniaJPRN-jRCTs041190054Higuchi Yuko
已完成
2 期
Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid SupplementationMajor DepressionCoronary Artery DiseaseSchizophreniaBipolar DisorderSchizoaffective DisorderNCT00167310University of Pittsburgh57
已完成
不适用
Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum DisordersAutismNCT00467818University of Medicine and Dentistry of New Jersey17
Unknown
4 期
Omega-3 Fatty Acids Efficacy in First-episode of SchizophreniaSchizophreniaNCT02210962Medical University of Lodz80
已完成
2 期
The efficacy of Omega 3 in the treatment of recurrent aphthous stomatitisRecurrent Aphtous Stomatitis.Recurrent oral aphthaeIRCT2015041620377N2Zahedan University of Medical Sciences50